Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Accounting for clinical action reduces estimates of gender disparities in lipid management for diabetic veterans.

Vimalananda VG, Miller DR, Hofer TP, Holleman RG, Klamerus ML, Kerr EA.

J Gen Intern Med. 2013 Jul;28 Suppl 2:S529-35. doi: 10.1007/s11606-013-2340-5.

2.

Gender Disparities in Lipid-Lowering Therapy in Cardiovascular Disease: Insights from a Managed Care Population.

Rodriguez F, Olufade TO, Ramey DR, Friedman HS, Navaratnam P, Heithoff K, Foody JM.

J Womens Health (Larchmt). 2016 Jul;25(7):697-706. doi: 10.1089/jwh.2015.5282. Epub 2016 Feb 18.

PMID:
26889924
3.

Gender disparities in lipid-lowering therapy among veterans with diabetes.

Vimalananda VG, Miller DR, Palnati M, Christiansen CL, Fincke BG.

Womens Health Issues. 2011 Jul-Aug;21(4 Suppl):S176-81. doi: 10.1016/j.whi.2011.04.009.

PMID:
21724138
4.

Assessing appropriateness of lipid management among patients with diabetes mellitus: moving from target to treatment.

Beard AJ, Hofer TP, Downs JR, Lucatorto M, Klamerus ML, Holleman R, Kerr EA; Diabetes Clinical Action Measures Workgroup.

Circ Cardiovasc Qual Outcomes. 2013 Jan 1;6(1):66-74. doi: 10.1161/CIRCOUTCOMES.112.966697. Epub 2012 Dec 11.

5.

Are there gender differences in diabetes care among elderly Medicare enrolled veterans?

Tseng CL, Sambamoorthi U, Rajan M, Tiwari A, Frayne S, Findley P, Pogach L.

J Gen Intern Med. 2006 Mar;21 Suppl 3:S47-53.

6.

LDL-C goal attainment among patients newly diagnosed with coronary heart disease or diabetes in a commercial HMO.

Nag SS, Daniel GW, Bullano MF, Kamal-Bahl S, Sajjan SG, Hu H, Alexander C.

J Manag Care Pharm. 2007 Oct;13(8):652-63.

7.

Decomposing gender differences in low-density lipoprotein cholesterol among veterans with or at risk for cardiovascular illness.

Sambamoorthi U, Mitra S, Findley PA, Pogach LM.

Womens Health Issues. 2012 Mar;22(2):e201-8. doi: 10.1016/j.whi.2011.08.012. Epub 2011 Dec 1.

PMID:
22133598
8.

Gender disparities in lipid management: the presence of disparities depends on the quality measure.

Kim C, Kerr EA, Bernstein SJ, Krein SL.

Am J Manag Care. 2006 Mar;12(3):133-6.

9.

Heart matters: Gender and racial differences cardiovascular disease risk factor control among veterans.

Goldstein KM, Melnyk SD, Zullig LL, Stechuchak KM, Oddone E, Bastian LA, Rakley S, Olsen MK, Bosworth HB.

Womens Health Issues. 2014 Sep-Oct;24(5):477-83. doi: 10.1016/j.whi.2014.05.005.

PMID:
25213741
10.

Statin Use and Its Facility-Level Variation in Patients With Diabetes: Insight From the Veterans Affairs National Database.

Pokharel Y, Akeroyd JM, Ramsey DJ, Hira RS, Nambi V, Shah T, Woodard LD, Winchester DE, Ballantyne CM, Petersen LA, Virani SS.

Clin Cardiol. 2016 Apr;39(4):185-91. doi: 10.1002/clc.22503. Epub 2016 Apr 5.

11.

Factors associated with treatment success in veterans with diabetes and hyperlipidemia: a retrospective study.

Tressler MC, Greer N, Rector TS, Ishani A, Ercan-Fang N.

Diabetes Educ. 2013 Sep-Oct;39(5):664-70. doi: 10.1177/0145721713492568. Epub 2013 Jun 19.

PMID:
23782624
12.

A retrospective cohort study of the potency of lipid-lowering therapy and race-gender differences in LDL cholesterol control.

Turner BJ, Hollenbeak CS, Weiner M, Tang SS.

BMC Cardiovasc Disord. 2011 Sep 30;11:58. doi: 10.1186/1471-2261-11-58.

13.

Association between statin adherence and cholesterol level reduction from baseline in a veteran population.

Kazerooni R, Watanabe JH, Bounthavong M.

Pharmacotherapy. 2013 Oct;33(10):1044-52. doi: 10.1002/phar.1305. Epub 2013 Jun 6.

PMID:
23744794
14.

Understanding disparities in lipid management among patients with type 2 diabetes: gender differences in medication nonadherence after treatment intensification.

Billimek J, Malik S, Sorkin DH, Schmalbach P, Ngo-Metzger Q, Greenfield S, Kaplan SH.

Womens Health Issues. 2015 Jan-Feb;25(1):6-12. doi: 10.1016/j.whi.2014.09.004. Epub 2014 Nov 22.

15.

Correlates of repeat lipid testing in patients with coronary heart disease.

Virani SS, Woodard LD, Wang D, Chitwood SS, Landrum CR, Urech TH, Pietz K, Chen GJ, Hertz B, Murawsky J, Ballantyne CM, Petersen LA.

JAMA Intern Med. 2013 Aug 12;173(15):1439-44. doi: 10.1001/jamainternmed.2013.8198.

PMID:
23817669
16.

Gender differences in composite control of cardiovascular risk factors among patients with type 2 diabetes.

Strom Williams JL, Lynch CP, Winchester R, Thomas L, Keith B, Egede LE.

Diabetes Technol Ther. 2014 Jul;16(7):421-7. doi: 10.1089/dia.2013.0329. Epub 2014 Apr 15.

17.
18.

Current lipid management and low cholesterol goal attainment in common daily practice in Spain. The REALITY Study.

García Ruiz FJ, Marín Ibáñez A, Pérez-Jiménez F, Pintó X, Nocea G, Ahumada C, Alemao E, Yin D; REALITY Study Group.

Pharmacoeconomics. 2004;22 Suppl 3:1-12.

PMID:
15669149
19.

Disparity in management of diabetes and coronary heart disease risk factors by sex in DCCT/EDIC.

Larkin ME, Backlund JY, Cleary P, Bayless M, Schaefer B, Canady J, Nathan DM; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group.

Diabet Med. 2010 Apr;27(4):451-8. doi: 10.1111/j.1464-5491.2010.02972.x.

PMID:
20536518
20.

Gender disparities in the quality of cardiovascular disease care in private managed care plans.

Chou AF, Scholle SH, Weisman CS, Bierman AS, Correa-de-Araujo R, Mosca L.

Womens Health Issues. 2007 May-Jun;17(3):120-30. Epub 2007 Apr 19.

PMID:
17448685

Supplemental Content

Support Center